Speculation on Big Pharmas looking at possible buyout
Strictly speculation but discussion of Big Pharma looking for companies in phase III studies focused on big ticket items (cancer, heart dz, triglycerides, etc). Anyone have ideas on which of the large pharmas currently would consider gobbling up SNSS to help their pipeline?
Not a bad thought since the DSMB basically said that our study was showing promise even though we may not currently know what that promise is.
Just makes sense if they can purchase us for roughly 8/share=$400MM instead spending resources and time of starting with IND and working it all the way to phase III with no certainty.
I think this is one of the underlying causes of our stock to continue to rise substantially.